Tuesday, January 03, 2023 10:04:10 AM
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production
https://www.reddit.com/r/RVVTF/comments/101z7y6/targeting_sarscov2_by_synthetic_dualacting_thiol/
Posted by u/_nicktendo_64
I'm hesitant to draw any conclusions about Bucillamine based on this study without some additional expert opinions. Any thoughts? One question comes to mind:
1. What concentrations of Bucillamine are possible within the cell?
https://www.reddit.com/r/RVVTF/comments/101z7y6/targeting_sarscov2_by_synthetic_dualacting_thiol/
Posted by u/_nicktendo_64
I'm hesitant to draw any conclusions about Bucillamine based on this study without some additional expert opinions. Any thoughts? One question comes to mind:
1. What concentrations of Bucillamine are possible within the cell?
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
